Belgian biotech Galapagos is mixing things up again via a plan to split in two, separating its innovative medicines and cell therapy businesses, which will result in the loss of around 300 jobs or ...

* Ex-Date is the date that the stock price is scheduled to adjust on the respective exchange. Cookies are essential for making our site work. By using our site, you consent to the use of these cookies ...